scriptional regulation of small intestinal gene expression controls plasma total cholesterol (TC) and triglyceride (TG) levels, which are major determinants of metabolic diseases. GATA4, a zinc finger domain transcription factor, is critical for jejunal identity, and intestinal GATA4 deficiency leads to a jejunoileal transition. Although intestinal GATA4 ablation is known to misregulate jejunal gene expression, its pathophysiological impact on various components of metabolic syndrome remains unknown. Here, we used intestinespecific GATA4 knockout (GATA4iKO) mice to dissect the contribution of GATA4 on obesity development. We challenged adult GATA4iKO mice and control littermates with a Western-type diet (WTD) for 20 wk. Our findings show that WTD-fed GATA4iKO mice are resistant to diet-induced obesity. Accordingly, plasma TG and TC levels are markedly decreased. Intestinal lipid absorption in GATA4iKO mice was strongly reduced, whereas luminal lipolysis was unaffected. GATA4iKO mice displayed a greater glucagon-like peptide-1 (GLP-1) release on normal chow and even after long-term challenge with WTD remained glucose sensitive. In summary, our findings show that the absence of intestinal GATA4 has a beneficial effect on decreasing intestinal lipid absorption causing resistance to hyperlipidemia and obesity. In addition, we show that increased GLP-1 release in GATA4iKO mice decreases the risk for development of insulin resistance.
ileal interposition; triglyceride absorption; obesity; glucagon-like peptide-1; CD36 THE ADULT DUODENAL-ILEAL AXIS is maintained through spatiotemporal gradients of transcription factors, which persist throughout the adult lifespan. These include Gata4, Gata5, Gata6, Hnf1␣, Cdx1, Cdx2, Pdx1, and the CCAAT displacement protein (CDP)/Cux (17, 42) . Several of these factors regulate expression of genes leading to physiological diversity of the three parts of the small intestine, the duodenum, jejunum, and ileum. However, their study in adulthood has been impeded due to embryonic lethal phenotypes of their respective knockouts. So far, six members have been assigned to the GATA family of zinc finger domain transcription factors that bind to the conserved promoter motif "WGATAR", identified as the GATA consensus site (31) . GATA4 was identified as a gene encoding a zinc finger domain transcription factor involved in development and organogenesis. However, its mRNA and protein are also expressed in adult tissues, including heart, adrenal glands, and small intestine (11, 44) .
Embryonic lethality in GATA4 knockout mice is known to arise mainly from defective heart tube formation and extraembryonic endoderm differentiation (33, 51) . In the small intestine, GATA4 mRNA expression is restricted to the duodenum and jejunum, and the expression is undetectable in the terminal ileum (17) . This expression pattern is conserved across several vertebrate species including humans (10) . GATA4 is expressed throughout the length of the crypt-villous axis in epithelial cells (9, 10) , where it regulates gene expression. It controls the expression of several genes that are important for carbohydrate, lipid, and sterol homeostasis and insulin secretion, including sucrase isomaltase, lactase (Lct), fatty acid-binding protein-1 (Fabp1), and glucose-dependent insulinotropic polypeptide (Gip) (10, 48) . Some of these genes are themselves expressed in distinct anteroposterior gradients with similar expression patterns to GATA4 (38, 41) .
Even though GATA4 has been implicated in regulating physiologically relevant intestinal genes, few studies have described its role in metabolic diseases. Bosse et al. (10) generated viable intestine-specific inducible GATA4 knockout mice. They showed that, in the jejunum, expression of jejunal markers such as Fabp1 and Lct was downregulated, whereas ileal markers such as solute carrier family 10, member 2 (Slc10a2 also known as Asbt) and Fabp6 were upregulated, suggesting a jejunal-ileal transition (10) . Using a villin-Cre approach, Battle et al. (5) generated intestine-specific GATA4 knockout (GATA4iKO) mice. The authors reported that 47% of ileal genes were ectopically expressed in jejunum of GATA4iKO mice and found a decrease (ϳ20%) in jejunal lipid uptake and absorption. The observed jejunoileal transition closely resembles the bariatric surgical procedure of ileal interposition. Kohli et al. (26) recently reported that, in rats that had undergone ileal interposition surgery, the cycling of bile acids was increased, and these mice were protected from obesity associated comorbidities. GATA4iKO mice showed a decreased expression of genes involved in lipid uptake and transport, such as Cd36 antigen (Cd36) and scavenger receptor class B type 1 (Scarb1) (5) . Both Cd36 and Scarb1 have been implicated in controlling triglyceride (TG) absorption in the small intestine (14, 29) . Compared with controls, GATA4iKO mice showed decreased body weights during suckling but had similar body weights after weaning (5). Whether these effects on body weight persist throughout the adult lifespan has not been addressed so far. Therefore, we hypothesized that the lack of GATA4iKO might compromise dietary fat absorption due to changes in expression of epithelial genes implicated in absorption of dietary fat. Given the role of distal intestinal L-cells in producing glucagon-like peptide-1 (GLP-1) and regulating glucose homeostasis, we hypothesized that the observed posteriorization of the intestine might positively impact insulin sensitivity. In the present study, we challenged adult GATA4iKO and control littermates with a Western-type diet (WTD) for 20 wk. Our findings revealed that GATA4iKO mice had decreased plasma TG levels and were resistant to dietinduced obesity. Due to increased levels of GLP-1, GATA4iKO mice exhibited preserved insulin sensitivity even upon long-term WTD feeding.
MATERIALS AND METHODS

Animals and diets. Generation of viable Gata4
loxP (Gata4tm1Sad), Gata4 null (Gata4tm1Eno), and VilCre [Tg(Vil-cre)997Gum] mice has been described previously (30, 33, 51) . Homozygous GATA4 LoxP mice were bred with the heterozygous GATA4
null VilCre mice to generate GATA4 LoxP/null VilCre intestine-specific knockouts (GATA4iKO) and GATA4
LoxP/ϩ VilCre controls. All experiments were performed on male mice. Mice had free access to food and water under a 12:12-h light-dark cycle in a temperature-controlled environment. Individually housed knockout and control littermates (n ϭ 10/group) were switched to a Western type diet (WTD) or continued on a normal chow diet (11.9% caloric intake from fat, Ssniff, Soest, Germany) at 6 wk of age. WTD contained 21% (wt/wt) crude fat and 0.15% (wt/wt) cholesterol and was Ϸ4.53 kcal/g (42% of calories from crude fat, 15% from protein, and 43% from carbohydrate; Ssniff). Mice were weighed weekly for a period of 20 wk.
Biochemical analysis. Blood was collected through the tail vein, and plasma was used for further determinations. Triglycerides (TG), total cholesterol (TC), and free fatty acids (FFA) were assayed in fed and fasted plasma with enzymatic kits according to the manufacturers' protocols (DiaSys, Holzheim, Germany; Wako Chemicals, Neuss, Germany). Plasma lipoproteins were separated using the Pharmacia P-500 fast protein liquid chromatography (FPLC) system and a Superose 6 column (Amersham Biosciences, Piscataway, NJ). Plasma was pooled (n ϭ 10/group), and TG concentrations in lipoprotein fractions were measured enzymatically. Plasma apolipoprotein profiles were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) separation followed by Coomassie blue staining. One microliter of freshly isolated plasma from fasted male mice was loaded onto a gradient polyacrylamide gel (4 -15%) for separation followed by an overnight Coomassie blue staining.
Enzyme-linked immunoassays (ELISA) were performed using kits for insulin and leptin (Crystal Chem, Downers Grove, IL), adiponectin (R&D Systems, Minneapolis, MN), and Gip (Millipore, Billerica, MA). GLP-1 was measured using radioimmunoassay (Linco Research, St. Charles, MI). Blood glucose levels were measured using Glucometer Accu-check-active (Roche Diagnostics, Palo Alto, CA).
For release assays of GLP-1 and Gip, overnight-fasted mice were gavaged with 200 l of corn oil (98% TG), and blood was drawn at various time points for analysis. Alternatively, to study the effect of increased GLP-1 on glucose-stimulated insulin release, overnightfasted mice were gavaged with 200 l of corn oil (98% TG). After 30 min, the mice were challenged with an oral glucose bolus (2 g/kg body wt). Plasma samples were drawn at various time points, and insulin levels were subsequently measured. ]oleate were simultaneously gavaged to fasted mice (n ϭ 4/group), and levels of both tracers were measured in plasma drawn at 0 h (before gavage) and at 1, 2, 4, and 6 h (after gavage) by liquid scintillation counting. Radioactive counts were presented as percent of dose per milliliter of plasma.
Histological staining. Sections (5 m) were prepared from formalin-fixed, paraffin-embedded gonadal white adipose tissues (WAT) from GATA4iKO and control mice (n ϭ 3/group) and subjected to hematoxylin and eosin staining using standard procedures.
Tissue distribution and fecal output of dietary fat. Uptake and incorporation of TG was studied in duodenum, jejunum, ileum, liver, WAT, and feces. Nonfasted mice on chow (n ϭ 4/group) were gavaged with 1 Ci [ 3 H]triolein in 200 l of corn oil. Four hours post-gavage, 1-cm segments of the duodenum (1 cm from pylorus), jejunum (1 cm of medial), and ileum (1 cm pre-cecum) were excised and flushed in 0.5 mM sodium taurocholate in PBS, and feces were collected. Tissues were weighed and solubilized in 1 ml of 1 N KOH at 65°C overnight, and feces were dried and pulverized. Radioactivity was measured by liquid scintillation counting and expressed as percentage of dose per gram of organ or feces. Additionally, the feces of both chow diet-(n ϭ 4/group) and WTD-fed mice (n ϭ 7/group) collected daily over a 4-day period were dried, pulverized, and subjected to Folch extraction (19) , with slight modifications. Briefly, tissues were weighed and homogenized, and lipids were extracted in chloroform-methanol (2:1) in a volume 20 times the weight of the sample. Lipid extracts were then solubilized in freshly prepared 0.2% Triton X-100 in chloroform, dried under nitrogen, and resuspended in water. FFA and TC were measured enzymatically.
Fecal fat balance. Seventy-two-hour fecal fat balance was measured as described previously (52) , with slight modifications. WTD and fecal pellets from mice (n ϭ 4/group) collected over 72 h were weighed, freeze-dried, and homogenized. Samples were hydrolyzed, derivatized, and measured using electron impact-gas chromatographymass spectrometry (EI-GC-MS) For preparation of trimethylsilyl ether derivatives, preweighed lyophilized material was transferred to Pyrex tubes and extracted according to the Folch procedure in the presence of 100 g of stearic-d35-acid (C18:0-d35, Isotec) as an internal standard to account for extraction efficiency. For quantification of FFA in mouse feces, 10 l of 1,000-l lipid extract were converted to the corresponding trimethylsilyl (Pierce, Rockford IL) ether derivatives in 100 l of MSTFA solution (ABCR, Karlsruhe, Germany), [MSTFA, containing 1% TMCS, in pyridine (2:1, vol/vol) for 60 min at 25°C, and stored at Ϫ20°C until GC-MS analysis]. To quantify total amounts of fatty acids in the diet, esterified fatty acids were hydrolyzed in 0.5 M NaOH at 90°C for 60 min, neutralized with 0.5 M HCl, extracted according to the Folch procedure, and derivatized as mentioned above. For EI-GC-MS, a Thermo Scientific Trace GC coupled to a DSQII mass spectrometer was used. The GC was fitted with an SGE BPX5 capillary column (15 m, ID 0.25 mm, 0.25 m methyl silicone film coating). The injector was operated in the splitless mode at 180°C. Helium was used as carrier gas at a flow rate of 1 ml/min. Initial column temperature was 80°C for 2 min, followed by an increase of 30°C/min to 170°C, an isothermal hold of 2 min, a second increase at 30°C/min to 230°C, an isothermal hold for 3 min, and increased by 20°C/min to 300°C with a hold for 3 min. The transfer line was kept at 310°C, and the ion source was 200°C. Electron impact spectra were recorded with electron energy of 70 eV and an emission current of 100 A. All samples were monitored either in full scan mode or using selected ion recording (SIR). SIR was performed at m/z ϭ 313 (C16:0; RT 8.97 min), m/z ϭ 341 (C18:0; RT 10.01 min), m/z ϭ 376 (C18:0-d35; RT 9.83 min), m/z ϭ 339 (C18:1; retention time 9.84 min), and m/z ϭ 337 (C18:2; RT 9.82 min). Quantification was performed by peak area comparison along with a standard calibration curve consisting of unlabeled primary fatty acid standards (Sigma, St. Louis, MO) mixed with the stable isotopelabeled standard. All solvents and reagents of analytical grade were from Sigma and Roth (Vienna, Austria). Absorption of four major dietary fatty acids (palmitate, stearate, oleate, linoleate) was determined as the difference between the amount of individual fatty acids ingested and excreted into feces over 72 h. The measurement was expressed as %total fat absorption ϭ fat intake (g/day) Ϫ fecal fat output (g/day) ϫ 100.
To measure fat intake (g/day), total fat absorption was quantified as the difference in fecal loss of the four major fatty acids from the total amount ingested.
RNA isolation and quantitative real-time PCR. Total RNA from tissues of mice fed WTD (n ϭ 5/group) and/or chow (n ϭ 5/group) was extracted using TRIzol reagent according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). Two micrograms of total RNA was reverse transcribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA). Quantitative real-time PCR was performed on a Roche LightCycler 480 (Roche Diagnostics, Palo Alto, CA) using the QuantiFastTM SYBR Green PCR Kit (Qiagen, Valencia, CA). Samples were run in triplicates for each experiment with cyclophilin A as an internal control. For analyzing the expression profiles and associated statistical parameters, the public domain program Relative Expression Software Tool -REST 2008 (http://www.gene-quantification.com/download.html) was used (39) . Primer sequences are available upon request.
In vivo MR imaging for body fat. Mice were anesthetized with Isoflurane according to the guidelines of the local steering committee. MR images were acquired at a 3T MRI system (Siemens Tim-Trio, Erlangen, Germany) with an eight-channel multipurpose coil (Noras MRI products, Hoechenberg, Germany) to maximize signal-to-noise ratio. For fat measurements, two T1 weighted 2D Turbo Spin Echo (TSE) sequences, one with spectral selective fat suppression and one without, were carried out. The following imaging parameters were used: TR, 800 ms; TE, 37 ms; TF, 5 ms. A field of view 90 ϫ 45 mm with a 384 ϫ 192 matrix provided an in-plane resolution of 230 ϫ 230 m with a slice thickness of 1.2 mm. Twelve excitations were averaged. For postprocessing for the fat quantification, the image without fat saturation was divided by its fat-saturated counterpart in order to cancel signal variations coming from coil non-uniformities. The ratio between the images was then interpreted as (fat ϩ water)/ water. Each pixel with a ratio of Ͼ1 was chosen for volume summation to get the collective fat volume over all images. This value was then multiplied by the mean fat fraction: [1 Ϫ water/(fat ϩ water)] to get the fat volume. All experiments had been approved by the Committee for Genetic Engineering and Animal Experimentation at the Austrian Federal Ministry of Science and Research (Vienna, Austria) and by the Ethics Committee for Animal Experiments of the Medical University of Graz.
Oral glucose tolerance test. An oral glucose tolerance test was performed as described previously (4, 18) . Briefly, blood was drawn through the tail vein from controls and GATA4iKO mice fasted for 6 h before gavage (0 min) and 15, 30, 60, and 120 min after an oral gavage of 2 g of D-glucose/kg body wt. Blood glucose levels were measured immediately using Glucometer Accu-check-active (Roche diagnostics, Palo Alto, CA).
Gastric emptying. Liquid gastric emptying was assessed in both genotypes as previously described (6, 32, 49) . Briefly, mice fasted overnight were challenged with oral gavage of 200 l (0.6 g/l) of phenol red in a glucose solution (6.5 mg/kg). Mice were killed by cervical dislocation after half an hour, and stomachs were collected in 0.1 N NaOH and homogenized. The homogenate was centrifuged at 8,500 rpm for 15 min. The supernatant (500 l) was treated with 50 l of TCA (20%) and centrifuged as above. Finally, supernatants were treated with 0.5 N NaOH (1:1 vol/vol) for maximum color development. Phenol red concentration in the mixture was then measured at 560 nM. Percent gastric emptying was calculated as %gastric emptying ϭ 1 Ϫ (amount of phenol red in the stomach Ϭ average amount recovered from control stomach) ϫ 100.
Statistical analysis. Plasma biochemical parameters in nonfasted and fasted states were compared independently. For body weights and plasma parameters, controls and GATA4iKO mice on chow and WTD were compared using two-parameter analysis of variance (two-way ANOVA) followed by a Bonferroni posttest. For oral glucose tolerance tests, differences between control and GATA4iKO groups were compared using the two-way ANOVA with repeated measures followed by a Bonferroni posttest. For absorption studies, intergroup differences were calculated using two-tailed, unpaired Student's t-test; P values Ͻ 0.05 were considered significant.
RESULTS
GATA4iKO mice exhibit decreased plasma lipid levels.
GATA4iKO mice fed a chow diet showed a slight but not significant decrease in plasma TG concentration in both fasted and nonfasted states (P ϭ 0.0546). On WTD, GATA4iKO mice showed 23 and 60% decreases in plasma TG concentrations in the fasted and nonfasted states, respectively, compared with controls (Table 1 ). This effect was mainly due to decreased VLDL/chylomicron-TG levels in GATA4iKO mice (Fig. 1A) . Levels of plasma apoB-100 and apoB-48 were also lower in plasma of WTD-fed GATA4iKO compared with control mice (Fig. 1A, bottom inset) . The food consumption in Values are means Ϯ SD. GATA4iKO, intestinal GATA4 knockout; WTD, Western-type diet; TG, triglycerides, TC, total cholesterol; FFA, free fatty acids. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. control. both groups was comparable (Fig. 1B) . Plasma TC concentrations were significantly decreased on the chow diet in both fasted (49%) and nonfasted (57%) states (Table 1) . On WTD, GATA4iKO mice showed 43 and 70% less plasma TC in fasted and nonfasted states, respectively, compared with controls. Nonfasted GATA4iKO mice had significantly lower plasma FFA concentrations in both chow diet-and WTD-fed mice compared with control mice (Table 1) . Plasma glucose levels in nonfasted mice were significantly reduced only in GATA4iKO mice fed the WTD (Table 1 ). In the fasted state, plasma FFA and glucose levels were comparable in GATA4iKO and control mice fed either the chow diet or WTD (Table 1) .
GATA4iKO mice exhibit impeded TG absorption. To investigate the underlying cause of reduced TG levels in plasma of GATA4iKO mice, we examined intestinal absorption and uptake of dietary fat. After oral administration of corn oil containing [
3 H]triolein, we observed delayed accumulation of lipids in plasma of GATA4iKO mice (Fig. 2, A and B) . GATA4iKO mice also showed decreased amounts of 3 H counts in duodenum and jejunum but not in ileum, suggesting a compromised enterocytic lipid uptake into the proximal small intestine compared with controls (Fig. 2C) . The excretion of fecal 3 H was higher in GATA4iKO mice than in controls (Fig.  2C) , confirming reduced intestinal absorption. In addition, we found decreased counts of 3 H in the liver and WAT (gonadal fat pads) (Fig. 2C) , which provides additional evidence for reduced intestinal absorption and incorporation into systemic lipid stores. GATA4iKO mice also exhibited higher fecal excretion of FFA (Fig. 2D) , especially on WTD, supporting a decreased lipid uptake. As an additional measure of dietary lipid malabsorption, we estimated the 72-h fecal fat balance, which revealed that GATA4iKO mice have defective absorption of three of the four major dietary lipid species (Fig. 2E) .
Palmitic acid (16:0) was decreased by 30.2%, oleic acid (18:1) by 25.5%, and stearic acid (18:0) by 14.3% (Fig. 2E) . Fecal weights tended to be higher in GATA4iKO mice than in controls, but the differences lacked statistical significance (Fig.  2F) . Additionally, the levels of fecal cholesterol, as determined enzymatically from fecal lipid extracts, were higher in GATA4iKO mice than in control mice fed WTD (Fig. 2G) .
Luminal lipolysis is not disturbed in GATA4iKO mice. To exclude the impact of differential luminal lipolytic activity on TG absorption, mice were gavaged with a combination of [ (Fig. 3A) and oleate (Fig. 3B ) was found to be decreased, resulting in an unchanged 3 H-to- 14 C ratio (Fig. 3C) , indicating an unchanged luminal lipolysis in GATA4iKO mice.
Intestinal expression of key absorptive genes is misregulated in GATA4iKO mice. To study the impact of GATA4 deficiency on mRNA levels of key duodenal and jejunal transporters involved in lipid uptake and absorption, we performed quantitative real-time PCR analysis from small intestines obtained from GATA4iKO and control mice fed both chow diet and WTD. We found downregulation of Cd36, fatty acid transport protein-2 (Fatp2), and Fabp1 in duodenum and jejunum of GATA4iKO compared with control mice on both diets (Fig. 4,  A and C) . Expression levels of Scarb1 in the duodenum and jejunum of GATA4iKO mice were decreased on chow diet but comparable to control mice when fed a WTD. Although plasma TC levels of GATA4iKO mice were significantly reduced on both diets (Table 1) , mRNA expression of the cholesterol transporter Niemann-Pick C1-like 1 (Npc1l1) in the duodenum and jejunum was comparable to that of controls fed either diet (Fig. 4, B and D) . In accord with previous studies (47, 53) , we also detected a significant increase in the expression levels of ATP-binding cassette transporter (ABC) G5 (Abcg5) and G8 (Abcg8) upon WTD in both genotypes (Fig. 4,   Fig. 1 . Plasma lipoprotein profile and food intake in intestinal GATA4 knockout (GATA4iKO) and control mice fed Western type diet (WTD). A: 200 l of pooled plasma from fasted mice fed WTD for 20 wk (n ϭ 10/group) were subjected to FPLC separation. Thirty-three fractions (500 l per fraction) were eluted, and triglyceride (TG) content in each fraction was measured enzymatically. Inset: levels of apoB-100 and apoB-48 in plasma. B: food intake in WTDfed mice was assessed in individually housed mice for 1 wk. Food consumption was monitored daily.
B and D). The mRNA expression level of hydroxylmethylglutaryl (Hmg)-CoA reductase was upregulated 2.8-fold in the liver of GATA4iKO mice (Fig. 4F) . To control for the lack of intestinal GATA4, we also measured the expression levels of small intestinal regional markers Fabp1 (proximal) and sodium/bile acid cotransporter (Asbt) (distal). Expression of Asbt was induced in the jejunum of GATA4iKO mice and was comparable to that of control ileum (Fig. 4E) . The expression of jejunal Fabp-1 of GATA4iKO mice was decreased compared with control jejunum (Fig. 4E) .
GATA4iKO mice are resistant to diet-induced obesity. Next, we examined the impact of intestinal GATA4 deficiency on body and adipose tissue mass in WTD-fed mice over a 20-wk period. We found that GATA4iKO mice weighed less from the beginning of the feeding study. This difference was even more pronounced during WTD feeding (Fig. 5A) . The decrease in weight gain was attributed to lower adipose tissue mass in GATA4iKO mice (Table 2) . Liver, heart, spleen, and brain showed comparable weights in both groups. To monitor body composition with regard to adipose tissue mass, GATA4iKO . G: cholesterol levels in fecal lipid extracts of mice fed chow diet (n ϭ 4/group) or WTD (n ϭ 7/group). Values are means Ϯ SE. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. controls. mice and their control littermates were subjected to T1-weighted magnetic resonance imaging. Figure 5B shows representative coronal sections of epidermal, retroperitoneal, gonadal, and perirenal fat pads of control and GATA4iKO mice in the 18th wk of WTD feeding. GATA4iKO mice exhibited a 2.7-fold decrease in the fat volume compared with control (8.0 vs. 21.7 ml). In addition, adipocytes from the gonadal fat pads of GATA4iKO mice fed WTD were of a smaller size (Fig. 5C ) and showed an intact regulation of two important adipokines, leptin and adiponectin. Fasting plasma leptin concentrations of WTD-fed GATA4iKO mice were as low as chow diet-fed mice (Fig. 5D) . Levels of adiponectin were higher in GATA4iKO mice fed either diet compared with WTD-fed control mice (Fig. 5E) .
GATA4iKO mice are glucose tolerant and insulin sensitive upon WTD feeding. To determine whether resistance to obesity was accompanied by increased insulin sensitivity, we measured plasma insulin levels and performed oral glucose tolerance test during the 18th wk of WTD feeding. GATA4iKO mice remained euinsulinemic in both nonfasted and fasted states (Fig. 6A ) and showed increased glucose tolerance compared with controls (Fig. 6B) . In chow diet-fed mice, insulin levels in both groups were comparable in fasted and nonfasted states (Fig. 6C) . However, GATA4iKO mice showed improved glucose tolerance even upon chow diet feeding (Fig. 6D) . Next, we assayed the release of GLP-1 in mice under both dietary conditions. GATA4iKO mice fed either diet had increased release of GLP-1 (Fig. 6, E and F) . Furthermore, the release of Gip (a proximal intestinal peptide) in response to fat load was attenuated to 33% (30-min time point) in GATA4iKO mice (Fig. 6G) , indicating that enteroendocrine factors are also subject to posteriorization, which might influence the malabsorption phenotype. An assay for glucose-stimulated insulin release upon fat load was performed. Although overall insulin levels were low due to overnight fasting, a 25% increase in the peak levels of plasma insulin in GATA4iKO mice was observed (Fig. 6H) . Finally, we investigated liquid gastric emptying in GATA4iKO mice, which was reduced by 24% in GATA4iKO mice compared with controls (Fig. 6I) .
DISCUSSION
Dietary lipids are predominantly absorbed by the proximal small intestine (duodenum and jejunum), whereas the terminal part (ileum) is mainly involved in bile acid reabsorption (35, 40) . Here, we report that the posteriorization of the small intestine caused by the lack of intestinal GATA4 has a beneficial effect of lowering plasma TG by reducing intestinal absorption and promoting resistance to diet-induced obesity. Over a 72-h period, GATA4iKO mice excreted greater amounts of dietary fatty acids, implying that the underlying cause of obesity resistance is their inability to absorb dietary lipids. The lack of GATA4 had profound effects on the expression of several genes involved in intestinal lipid uptake and transport. This included the downregulation of Cd36, Fatp2, Fabp1, and Scarb1, genes involved in fatty acid and cholesterol uptake and/or transport (16, 21, 29, 34) . The expression of all these transporters with the exception of Scarb1 was downregulated independently of whether mice were fed WTD or chow diet. However, Scarb1 expression was downregulated only in GATA4iKO mice fed chow diet. WTD is known to increase the levels of intestinal Scarb1 mRNA and protein in mice, and this contributes to the regulation of transintestinal cholesterol excretion (TICE) (47) . Our finding implies that alternative pathways operating independently of GATA4 might regulate intestinal Scarb1 expression on WTD. Apart from the reduced plasma TG concentrations, GATA4iKO mice also have reduced plasma TC levels. However, the expression of the well-established cholesterol importer Npc1l1 was unchanged on both dietary regimens and genotypes. Based on our observations, there are several possible explanations for the decrease in plasma TC levels in GATA4iKO mice. 1) Downregulation of Cd36 might be extremely relevant, since a number of studies have proposed that Cd36 is a putative cholesterol importer (29, 40, 46) . It was recently shown that Cd36 regulates cholesterol uptake into the proximal but not distal intestine (34) . The ileal expansion observed in GATA4iKO mice lends further support for Cd36 as an important component for cholesterol uptake and or transport in the proximal intestine.
2) Our observation of increased fecal excretion of cholesterol in GATA4iKO mice fed WTD leads to the possibility of enhanced TICE as a probable cause of reduced plasma TC levels. Since GATA4 mice display defective patterning in the anteroposterior intestinal axis, it would be interesting to investigate the possible effects on TICE that have greater involvement of the proximal intestine. 3) Given the upregulated Hmg-CoA reductase mRNA in the livers of GATA4iKO mice, a lower cholesterol synthesis would be improbable to account for the drastic reduction in the plasma TC concentration. Our results taken together with the previous report from Battle et al. (5) confirm that the most likely cause of the reduced plasma TC levels in GATA4iKO mice is the lower intestinal absorption owing to reduced expression of Cd36. Defective luminal lipolysis or improper bile acid release could be another explanation for the general reduction in intestinal TG and TC absorption.
However, coadministration of [ 3 H]triolein and [ 14 C]oleate revealed that luminal lipolytic activities were comparable between GATA4iKO and control mice. Therefore, differences in activity of luminal lipases or formation of micelles do not account for the observed reduction in lipid absorption in GATA4iKO mice. In a recent study, GATA4iKO mice were shown to have a normal bile acid pool size, except for enhanced retention of tauro-␤-muricholic acid (7) . These findings support our observation that changes in luminal lipolysis do not account for the reduced lipid absorption seen in GATA4iKO mice. Reduced TG absorption of GATA4iKO mice effectively translated into a long-term obesity resistance. Energy balance and food intake is regulated through a complex interaction of hormones produced in the periphery and central nervous system. Findings of the present study demonstrate that intestinal GATA4 deficiency results in a shift of hormone production toward a metabolic situation efficiently counteracting obesity and hyperglycemia, as well as leptin and insulin resistance, major pathophysiological components of the metabolic syndrome. Plasma leptin is an indicator of body fat, and its circulating levels are suppressed upon fasting. Failure to respond to fasting by a decrease of plasma leptin levels is associated with obesity and is termed as peripheral leptin resistance (15, 22, 24) . WTD-fed GATA4iKO mice failed to develop peripheral leptin resistance and exhibited lower levels of fasting plasma leptin, reflecting an intact physiological regulation of leptin in these mice.
A second adipose-derived hormone significantly impacting on energy balance is adiponectin. It exerts an anti-diabetic and anti-atherogenic effect and plays an important role in the regulation of lipid and glucose metabolism. Adiponectin levels are inversely proportional to body fat (2, 28) . In line with lower fat volume and smaller adipocyte size, plasma adiponectin levels were higher in GATA4iKO mice compared with controls fed WTD. With regards to intestinal hormone production relevant to energy homeostasis, we observed increased GLP-1 and decreased Gip production. As described previously, a mechanism leading to a partial jejunoileal homeosis is opera- Values are means Ϯ SD in grams. WAT, gonadal white adipose tissue; BAT, intrascapular brown adipose tissue. Results are expressed relative to total body weight of 9 mice per group. *P Ͻ 0.05, ***P Ͻ 0.001 vs. control. tive in GATA4iKO mice (5, 10) . This phenotype closely resembles ileal interposition, a form of bariatric surgery. In rats subjected to ileal interposition, obesity-related morbidities decrease (26) . The interposed ileum adapts to surgical transposition but retains its ability to absorb bile acids and to release GLP-1, an ileal enteroendocrine peptide (12, 26) . GLP-1 release is potentiated by the presence of dietary lipids (45) . GLP-1 mainly enhances peripheral insulin sensitivity and stimulates glucose-dependent insulin release from the pancreatic ␤-cells (23, 37) . We thus hypothesized that the ileal expansion in GATA4iKO mice would cause an increase in GLP-1. Concurrently, in GATA4iKO mice, GLP-1 release was elevated, which was reflected in a preserved glucose tolerance on both diets. Increased GLP-1 release in GATA4iKO mice was coupled with higher glucose-stimulated insulin release upon oral fat load. Insulin itself is known to inhibit the synthesis of TG-rich lipoproteins such as chylomicrons. Thus, the increased insulin release might be seen as an additional mechanism for decreased lipid absorption. Other physiological effects of GLP-1 include inhibition of gastric emptying. Consequently, GATA4iKO mice showed a slower liquid gastric emptying, which could explain, at least in part, the delayed appearance of triolein in plasma. Following ileal interposition surgery, the levels of Gip, a proximal intestinal enteroendocrine peptide, were shown to be decreased (12) . Gip potentiates chylomicron production (43) . Accordingly, we found that lack of intestinal GATA4 also led to decreased levels of circulating Gip. Gip release upon oral fat load was also lower in GATA4iKO mice. Fig. 6 . Glucose tolerance and insulin sensitivity in GATA4iKO mice after WTD feeding. Plasma insulin concentrations were determined in nonfasted and fasted states in control and GATA4iKO mice in the 18th wk of WTD feeding (n ϭ 5/group) (A) and 11th wk of chow diet feeding (n ϭ 4/group) (C). Glucose tolerance tests were performed in control and GATA4iKO mice fed either WTD (B), or chow diet (D) (n ϭ 4/group). Glucagon-like peptide-1 (GLP-1) release in control and GATA4iKO mice fed WTD (E), or chow diet (F) (n ϭ 4/group). Glucose-dependent insulinotropic polypeptide (Gip; G) and insulin (H) release upon oral fat load in control and GATA4iKO mice fed chow diet (n ϭ 4/group). I: Percent liquid gastric emptying in control and GATA4iKO mice fed chow diet (n ϭ 4/group). Values represent means Ϯ SE. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. controls.
These findings point to a possibility of decreased Gip release being an additional mechanism for the reduced TG absorption in GATA4iKO mice. In a canine model, Gip was shown to increase peripheral fat deposition by enhanced chylomicron clearance (50) . In another study, it was found that Gip activates lipoprotein lipase on adipocytes and thus enhances lipid deposition (25) . Therefore, lower Gip levels imply reduced adiposity as encountered in GATA4iKO mice. On the basis of our data, we conclude that intestinal lack of GATA4 could alleviate at least two components of the metabolic syndrome: dietinduced obesity and type 2 diabetes mellitus. Given the cholesterol-lowering effects of intestinal knockout of GATA4, it would be interesting to investigate its ability to reduce atherosclerosis susceptibility. Although direct clinical data are limited, an increasing number of studies present ileal interposition surgery as a novel and effective mode for treatment of type 2 diabetes mellitus (1, 3, 13, 27) . In this respect, GATA4iKO mice are an interesting model to recapitulate the effects of ileal interpositioning, but they also provide a potential target for drug discovery.
